『Penile Traction Therapy by SizeGenetics - Canada』のカバーアート

Penile Traction Therapy by SizeGenetics - Canada

Penile Traction Therapy by SizeGenetics - Canada

著者： SizeGenetics - Canada
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 SizeGenetics — Science-first education about FDA-registered traction therapy from the inventors of the category (1994). Clinically proven. Over 1,000,000 devices sold worldwide. We're the official YouTube channel for SizeGenetics, an FDA-registered Class II medical device developed by Danamedic ApS in Denmark. Danamedic didn't just make a penile traction device — they invented penile traction therapy itself in 1994. That's 32 years of clinical engineering, over 1,000,000 devices sold, and a body of evidence spanning 15+ peer-reviewed studies. SizeGenetics was co-invented by Dr. Jorn Ege Siana, a plastic surgeon, alongside medical advisors Dr. Finn Worm Knudsen and Dr. Michael Carter. The device delivers calibrated traction of up to 3,200 grams using the same tissue expansion science that surgeons have relied on for decades in reconstructive medicine.@2026SizeGenetics - Canada 衛生・健康的な生活
エピソード
  • Penile Traction Therapy Safety: 30 Years of Clinical Data | SizeGenetics

    Penile Traction Therapy Safety: 30 Years of Clinical Data | SizeGenetics
    2026/04/16

    Episode Summary

    Over 30 years of clinical research involving 1,000+ patients demonstrates that penile traction therapy with an FDA-registered Class II medical device has zero serious adverse events. This episode breaks down the safety data from 15+ peer-reviewed studies and explains what temporary side effects actually mean for treatment outcomes.

    Key Findings

    • Zero Serious Adverse Events: 30+ years of clinical research across 1,000+ patients with no serious complications reported
    • 2023 Meta-Analysis: Almsaoud, Safar, and Alshahrani confirmed safety across 12 pooled clinical studies in Translational Andrology and Urology
    • Mild Adverse Event Rate: 11-14% temporary effects (skin irritation within 24 hours, discomfort resolves immediately, transient numbness 30-60 minutes)
    • Patient Satisfaction: 87% repeat rate and 93% recommendation rate in randomized controlled trials
    • Therapeutic Tension Range: SizeGenetics delivers 900-2,800 grams (8.8-27.5 Newtons) within evidence-established safety window

    The Science

    Penile traction therapy applies controlled mechanical tension to penile tissue, stimulating collagen remodeling and cellular adaptation within the tunica albuginea and corpora cavernosa. The therapeutic tension window (900-2,800 grams) is calibrated based on three decades of clinical safety data, ensuring efficacy without tissue damage.

    About SizeGenetics

    FDA-registered Class II medical device manufactured by Danamedic ApS in Denmark since 1994 — the company that invented penile traction therapy. Delivers calibrated tension of 900–2,800 grams within the exact therapeutic range established by clinical studies. Over 1 million units sold worldwide. Co-invented by Dr. Jørn Ege Siana, plastic surgeon and medical advisor based in Copenhagen.

    Resources

    • Full Guide: Penile Traction Therapy Safety
    • Penile Traction Therapy: Clinical Evidence and Mechanism
    • Clinical Studies: 15+ Peer-Reviewed Research
    • Treatment Protocol: Safe Usage Guidelines

    Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.
    続きを読む 一部表示
    4 分
  • Penile Traction Therapy Results (15+ Studies) | SizeGenetics

    Penile Traction Therapy Results (15+ Studies) | SizeGenetics
    2026/04/10

    Episode Summary

    What results can you actually expect from penile traction therapy? In this episode, we break down 15+ peer-reviewed clinical studies involving over 1,000 patients — real measured outcomes, not marketing claims.

    Key Findings

    • Average length gain: 1.3–2.3 cm over 3–6 months of daily use across 15+ studies
    • 2023 meta-analysis (Almsaoud et al.): 12 studies, 1,000+ patients, 1.9 cm weighted mean gain
    • Joseph 2020 RCT: 110 participants, 94% achieved measurable length increases (1.6–2.3 cm)
    • Toussi 2021 RCT: 82 men, traction group gained 1.6 cm vs. 0.3 cm control (p < 0.01)
    • Safety: Zero serious adverse events reported across all major clinical trials
    • Patient satisfaction: 87% would repeat therapy, 93% would recommend it

    The Science

    Penile traction works through mechanotransduction — the cellular response to sustained mechanical force. The same biological principle used in orthopedic limb lengthening and tissue reconstruction for decades.

    About SizeGenetics

    FDA-registered Class II medical device, manufactured by Danamedic ApS in Denmark since 1994. Delivers calibrated tension of 900–2,800 grams — the exact therapeutic range used in clinical studies. Over 1 million units sold worldwide.

    Resources

    • 📖 Full Guide: Results & Expected Outcomes
    • 🔬 Clinical Studies & Evidence
    • ⚙️ How Penile Traction Therapy Works
    • 🛡️ Safety & Side Effects
    • 📏 How to Measure Correctly

    ⚕️ Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any treatment.
    続きを読む 一部表示
    4 分
まだレビューはありません